NCT00505037View on ClinicalTrials.gov

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
HyperphosphatemiaChronic Kidney Disease
Interventions
DRUG

ASP1585

Oral

DRUG

Placebo

Oral

DRUG

Sevelamer hydrochloride

Oral

Trial Locations (6)

Unknown

Chugoku

Chūbu

Kansai

Kanto

Kyushu

Shikoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY